Routti Jorma 4
4 · FIBROGEN INC · Filed Jul 11, 2018
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Routti Jorma
Director
Transactions
- Exercise/Conversion
Common Stock
2018-07-09$18.00/sh+6,000$108,000→ 137,540 total - Sale
Common Stock
2018-07-09$67.71/sh−6,000$406,260→ 131,540 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-07-09−6,000→ 6,000 totalExercise: $18.00Exp: 2024-11-13→ Common Stock (6,000 underlying)
Footnotes (3)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]The shares were sold at prices ranging from $67.25 to $68.175. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Fully vested.